Carl Icahn : Bristol-Myers in $4.5bn ImClone bid

Hedge Fund Tycoons • Energy Tycoons • Media Tycoons • Real Estate Tycoons • Stock Market Tycoons • Technology Tycoons • Music Tycoons • Movie Tycoons • Fashion Tycoons • Sports Tycoons • Publishing Tycoons • Food Tycoons

Adult Entertainment • Bankruptcies • Casino & Gaming • Deregistration • Goldman Sachs • Hedge Fund Holdings • Internet Advertising • Loan Defaults • Material Deficiencies • Net Operating Losses • Poison Pills • Restatements • Rights Offering • Shareholder Rights Plans • Spinoffs • Subprime Loans • XBRL in Filings

Backdated Options • Insider Trading Plans • Stock Option Expense

Alibaba.com • CreditCard.com • Blackstone Group • Lockup Expirations

Blackstone Group • Carlyle Group • Connecticut Hedge Funds • Hedge Fund Holdings • SAC Capital

Abu Dhabi • Iran • Iraq • Kuwait • Libya • Nigeria • Oman • Qatar • Russia • Saudi Arabia • UAE • Venezuela

FREE access to SEC EDGAR filings and business news. Specific subjects included are the year 2007 total compensation of the highest paid company executives, new IPO's; subprime loans; Big Winners; Big Losers, Insider Trades; Backdated Options; "Tycoons" like Carl Icahn, George Soros, Sumner Redstone, and Warren Buffett; late SEC Filers, auditor changes, poison pills

Advanced Search – Enter the ticker symbol of the company and the name of A person. EXAMPLE: To find all stories and related SEC filings on Carl Icahn's efforts to gain control of Motorola, search for "MOT Carl Icahn".

Carl Icahn

Bristol-Myers in $4.5bn ImClone bid - Financial Times

Bristol-Myers in $4.5bn ImClone bid
Financial Times, UK - 3 hours ago
... ImClone it does not already own for $4.5bn, leaving Carl Icahn, the chairman of the biotechnology company, to decide whether to negotiate over a deal. ...

Published Thursday, July 31, 2008 8:44 PM

This Blog

Home
Links

Carl Icahn

Bristol-Myers in $4.5bn ImClone bid - Financial Times

This Blog

Syndication

Recent Posts

Tags

Archives